NUCALA

Google image searchProduct monograph

Active ingredient

mepolizumab, 40 MG/0.4 ML

DIN: 02530821

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-USE PRE-FILLED SYRINGE

Schedule: Prescription / Schedule D

Company: GLAXOSMITHKLINE INC

Date: 13-FEB-2023

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03D — OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD)
• R03DX — Other systemic drugs for obstructive airway diseases (ATC, ATC/DDD)
• R03DX09 — MEPOLIZUMAB (ATC/DDD)

External Links for Nucala

Search on Google

• Nucala side effects
• Nucala dosage
• mepolizumab side effects
• mepolizumab dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find nucala photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.